Stock Analysis

UK Value Stocks That Might Be Priced Below Intrinsic Estimates In October 2024

Published

The United Kingdom market has remained flat over the last week but is up 6.5% over the past year, with earnings forecasted to grow by 14% annually. In this environment, identifying stocks that may be priced below their intrinsic value can offer investors potential opportunities for growth and resilience.

Top 10 Undervalued Stocks Based On Cash Flows In The United Kingdom

NameCurrent PriceFair Value (Est)Discount (Est)
GlobalData (AIM:DATA)£1.96£3.7247.2%
S&U (LSE:SUS)£19.20£36.5847.5%
Informa (LSE:INF)£8.27£16.1348.7%
Redcentric (AIM:RCN)£1.20£2.3949.8%
Gulf Keystone Petroleum (LSE:GKP)£1.298£2.4647.2%
Loungers (AIM:LGRS)£2.71£5.4149.9%
Foxtons Group (LSE:FOXT)£0.64£1.2046.7%
SysGroup (AIM:SYS)£0.325£0.6549.9%
BATM Advanced Communications (LSE:BVC)£0.19£0.3748.4%
Genel Energy (LSE:GENL)£0.78£1.5148.2%

Click here to see the full list of 59 stocks from our Undervalued UK Stocks Based On Cash Flows screener.

We'll examine a selection from our screener results.

Smith & Nephew (LSE:SN.)

Overview: Smith & Nephew plc develops, manufactures, markets, and sells medical devices and services globally, with a market cap of £9.55 billion.

Operations: The company's revenue segments include Orthopaedics at $2.26 billion, Sports Medicine & ENT at $1.77 billion, and Advanced Wound Management (AWM) at $1.61 billion.

Estimated Discount To Fair Value: 33.8%

Smith & Nephew is trading at £10.85, significantly below its estimated fair value of £16.39, suggesting it may be undervalued based on cash flows. Despite high debt levels and a dividend not well covered by earnings or free cash flows, the company's strategic collaborations like the recent co-marketing agreement with JointVue for 3D surgery planning technology could enhance operational efficiency and patient outcomes. Earnings are forecast to grow annually by 22.75%, outpacing the UK market's growth rate.

LSE:SN. Discounted Cash Flow as at Oct 2024

Senior (LSE:SNR)

Overview: Senior plc designs, manufactures, and sells high-technology components and systems for major original equipment manufacturers in aerospace, defense, land vehicle, and power and energy markets globally; it has a market cap of £551.24 million.

Operations: The company's revenue is derived from two main segments: Aerospace, contributing £651.10 million, and Flexonics, accounting for £333 million.

Estimated Discount To Fair Value: 37.3%

Senior plc is trading at £1.35, well below its estimated fair value of £2.15, indicating potential undervaluation based on cash flows. Despite a forecasted low return on equity of 9% in three years, earnings are expected to grow significantly at 31.5% annually, outpacing the UK market's growth rate. Recent developments include securing contracts with Deutsche Aircraft and Rolls-Royce, which may bolster future revenue streams despite current challenges in net income performance.

LSE:SNR Discounted Cash Flow as at Oct 2024

Savills (LSE:SVS)

Overview: Savills plc, along with its subsidiaries, provides real estate services across the United Kingdom, Continental Europe, Asia Pacific, Africa, North America, and the Middle East with a market cap of £1.54 billion.

Operations: The company's revenue segments consist of Consultancy (£464.80 million), Transaction Advisory (£803.60 million), Investment Management (£100.50 million), and Property and Facilities Management (£920.90 million).

Estimated Discount To Fair Value: 24.6%

Savills is trading at £11.4, significantly below its estimated fair value of £15.12, suggesting it may be undervalued based on cash flows. Earnings are projected to grow at 33.3% annually, surpassing the UK market's growth rate. However, profit margins have declined from 3.8% to 1.9%. Recent strategic moves include appointing Toby Hall to enhance their commercial agency services in the Middle East amidst regional growth opportunities, potentially impacting future revenue positively.

LSE:SVS Discounted Cash Flow as at Oct 2024

Turning Ideas Into Actions

Ready For A Different Approach?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com